Rimm DL - Search Results

1

Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib.

Wilson MA, Zhao F, Letrero R, D'Andrea K, Rimm DL, Kirkwood JM, Kluger HM, Lee SJ, Schuchter LM, Flaherty KT, Nathanson KL. Wilson MA, et al. Among authors: rimm dl. Clin Cancer Res. 2014 Jun 15;20(12):3328-37. doi: 10.1158/1078-0432.CCR-14-0093. Epub 2014 Apr 8. Clin Cancer Res. 2014. PMID: 24714776 Free PMC article. Clinical Trial.

2

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

3

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

4

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

5

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL. Chung GG, et al. Among authors: rimm dl. Clin Cancer Res. 2001 Dec;7(12):4013-20. Clin Cancer Res. 2001. PMID: 11751495

6

Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.

Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL, Rimm DL. Kielhorn E, et al. Among authors: rimm dl. Int J Cancer. 2003 Feb 20;103(5):652-6. doi: 10.1002/ijc.10893. Int J Cancer. 2003. PMID: 12494474

7

Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.

Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Dolled-Filhart M, et al. Among authors: rimm dl. Clin Cancer Res. 2003 Feb;9(2):594-600. Clin Cancer Res. 2003. PMID: 12576423

8

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

Camp RL, Dolled-Filhart M, King BL, Rimm DL. Camp RL, et al. Among authors: rimm dl. Cancer Res. 2003 Apr 1;63(7):1445-8. Cancer Res. 2003. PMID: 12670887

9

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.

Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL. Tolgay Ocal I, et al. Among authors: rimm dl. Cancer. 2003 Apr 15;97(8):1841-8. doi: 10.1002/cncr.11335. Cancer. 2003. PMID: 12673709 Free article.

10

Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization.

King BL, Tsai SC, Gryga ME, D'Aquila TG, Seelig SA, Morrison LE, Jacobson KK, Legator MS, Ward DC, Rimm DL, Phillips RF. King BL, et al. Among authors: rimm dl. Clin Cancer Res. 2003 Apr;9(4):1509-16. Clin Cancer Res. 2003. PMID: 12684427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters